Dr. Elizabeth Nabel's stock sales have infuriated a number of Brigham and Women’s employees
The head of Brigham and Women’s Hospital sold nearly $2 million worth of Moderna stock in May, just as the institution she led was preparing cost-cutting due to COVID-19, bringing her total earnings from the biotech company to $8.5 million this year.

Nabel resigned from the Cambridge biotech’s board of directors Thursday amid concerns that her position there might conflict with the hospital’s role in a large study of the vaccine.

Read the full story.
Brigham president resigns from Moderna board after conflict of interest questions raised

We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
Like us
Follow us
You received this message because you signed up for Breaking News Alerts.

Copyright © 2020 The Boston Globe, All rights reserved.

Our mailing address is:
The Boston Globe
1 Exchange Place Suite 201
Boston, MA 02109-2132

Add us to your address book


unsubscribe from this list

Manage Your Account | Terms of Service | Privacy Policy | Help Center | Advertise